Vanguard Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3M Sell
3,558,591
-157,268
-4% -$609K ﹤0.01% 2737
2026
Q2
$17.4M Buy
3,715,859
+218,247
+6% +$895K ﹤0.01% 2527
2026
Q1
$14.4M Buy
+3,497,612
New +$13.1M ﹤0.01% 2522

Other funds holding XFOR

Vanguard Capital Management's XFOR Position: Q3 2026 in Review

Vanguard Capital Management reduced its X4 Pharmaceuticals (XFOR) stake by 4.2% in Q3 2026, selling an estimated $609K and leaving 3,558,591 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2737.

Vanguard Capital Management first reported a position in XFOR in Q1 2026 and has held it in 3 quarters since. The position peaked at $17.4M in Q2 2026. 97 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.

  • Vanguard Capital Management held 3,558,591 shares of X4 Pharmaceuticals worth $10.3M as of Q3 2026.
  • Vanguard Capital Management sold 157,268 X4 Pharmaceuticals shares in Q3 2026, an estimated $609K.
  • X4 Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2737 holding.
  • Vanguard Capital Management first reported a position in X4 Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's X4 Pharmaceuticals position peaked at $17.4M in Q2 2026.
  • 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.